Re: “Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Haemostasis and Thrombosis”, by Ross I Baker, Paul B Coughlin, Alex S Gallus, et al on behalf of the Warfarin Reversal Consensus Group (Med J Aust 2004; 181: 492-497). In Box 5, an asterisk in the Box title should have attributed Prothombinex-HT to CSL Limited, the manufacturer of all plasma-derived therapeutic products fractionated from Australian plasma.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Thrombosis and Haemophilia Service, Royal Perth Hospital, Perth, WA.
- 2 Monash University, Box Hill Hospital, Box Hill, VIC.
- 3 SouthPath, Flinders Medical Centre, Bedford Park, SA.
- 4 Auckland City Hospital, Auckland, New Zealand.
- 5 Australian Red Cross Blood Service, Southbank, VIC.